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Differentiation into a nerve cell-like phenotype and
growth arrest of SH-SY5Y neuroblastoma cells went along
with increased cAMP formation. Both receptor-dependent
as well as direct activation of adenylyl cyclase by forskolin
were enhanced by at least twenty-fold. Since cAMP con-
trols many processes in nerve cell function and develop-
ment we have investigated the causal factors and
mechanism of sensitization in SH-SY5Y cells. The degree
of sensitization depended on pre-incubation of the cells
with retinoic acid; however, maximizing the extent of sen-
sitization required the withdrawal of serum from the cul-
ture medium. This was necessary for the cells to secrete
endogenous substances into the culture supernatant.
Because sensitization was blocked by inhibitors of gene
transcription we surmised that the autocrine factors were
relevant for sensitization and were generated by de novo
protein synthesis. A gene expression screen revealed sev-
eral factor candidates (including dkk1, EphB2, NPY,
VEGFB); our preliminary data indicated that a combina-
tion of these may be needed to induce full sensitization.
Our data further suggest that sensitization was not due to
up-regulation of stimulatory G proteins or adenylyl
cyclase. Rather, the immediate cause may be clustering of
the catalyst and its activator Gs. This interpretation is con-
sistent with the effect caused by altering the membrane
lipid composition which enhanced and reduced cAMP
formation in undifferentiated and differentiated cells,
respectively.
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